- ►endojournals.org U Pagotto, G Marsicano, D Cota, B Lutz, R … - Endocrine reviews, 2006 - Endocrine Soc During the last few years, the endocannabinoid system has emerged as a highly
relevant topic in the scientific community. Many different regulatory actions
have been attributed to endocannabinoids, and their involvement in several ... Cited by 251 - Related articles - BL Direct - All 14 versions
GA Bray, DH Ryan - Gastroenterology, 2007 - Elsevier Three medications with approval for long-term use in the treatment of obesity
are currently available in the United States. Sibutramine (US Food and Drug
Administration [FDA] approved in 1997), orlistat (FDA approved in 1999), ... Cited by 48 - Related articles - All 20 versions
GT Chew, SK Gan, GF Watts - Medical Journal of Australia, 2006 - mja.com.au Evolving concept and clinical spectrum An association between hypertension,
hyperglycaemia and hyper- uricaemia was first reported over 80 years ago.2
Subsequently, this cluster was expanded to include upper body ... Cited by 35 - Related articles - View as HTML - BL Direct - All 4 versions
M Lee, LJ Aronne - The American Journal of Cardiology, 2007 - Elsevier Most patients with type 2 diabetes mellitus are overweight or obese, and the
relation between obesity, especially of the visceral compartment, and the risk
for developing diabetes is well recognized. Excessive adipose tissue is ... Cited by 35 - Related articles - All 29 versions
P Portincasa, I Grattagliano, VO Palmieri, G … - Current medicinal chemistry, 2006 - ingentaconnect.com Abstract: Nonalcoholic fatty liver disease (NAFLD) is a frequent and potentially
progressive chronic liver disease that occurs in subjects who do not abuse
alcohol. NAFLD is often associated with obesity, metabolic syndrome and ... Cited by 26 - Related articles - BL Direct - All 6 versions
- ►kfcpt.org [PDF] H Bays, CA Dujovne - Current atherosclerosis reports, 2006 - Springer Current guidelines recommend that weight-loss therapy should be primarily based
upon specific body mass index (BMI) cut-off limits. However, in the adipocentric
paradigm, it is acknowledged that co-morbidities, such as type 2 diabetes ... Cited by 21 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org J Rosenstock, P Hollander, KM Gadde, X Sun, … - Diabetes care, 2007 - Am Diabetes Assoc RESULTS—A total of 111 subjects were randomized and analyzed. By the end of
week 16, patients in the placebo and topiramate groups lost 2.5 and 6.0 kg,
which represented 2.3 and 5.8%, respectively, of their baseline body weight ... Cited by 13 - Related articles - BL Direct - All 5 versions
MA Rubio, M Gargallo, A Isabel Millán, B … - Public health nutrition, 2007 - Cambridge Univ Press 1 Department of Endocrinology and Nutrition, Hospital Clın San Carlos, c/
Martın Lagos s/n, 28040 Madrid, Spain: 2 Department of Endocrinology and
Nutrition, Hospital Virgen de la Torre, Madrid, Spain: Cited by 11 - Related articles - BL Direct - All 3 versions
